Skip to main content

Table 3 Impact of the SNP, RBCs total n-3 PUFA and the interaction SNP * RBCs total n-3 PUFA on plasma lipids and lipoproteins levels

From: Omega-3 fatty acids, polymorphisms and lipid related cardiovascular disease risk factors in the Inuit population

 

SNP

P-value for SNP

P-value for n-3 PUFA

Genotype/ Frequency

β ± SEM

P-Value for Interaction effect

Total cholesterol (TC)

AGT

0.1453

0.4455

C/C (71%)

0a

0.0448

M235T

C/T (26%)

0.0210 ± 0.0262a

rs699*

T/T (3%)

−0.1482 ± 0.0651b

CETP

0.0152

<0.0001

C/C (36%)

0a

0.0326

C-4502T

C/T (49%)

−0.0632 ± 0.0241b

rs183130

T/T (15%)

−0.0421 ± 0.0343ab

CETP

0.1115

0.0002

C/C (26%)

0ab

0.0334

Ile405Val

C/T (47%)

0.0397 ± 0.0268a

rs5882*

T/T (26%)

−0.0290 ± 0.0307b

LDL-Cholesterol (LDL-C)

AGT

0.1514

0.6339

C/C (71%)

0a

0.0405

M235T

C/T (26%)

0.0299 ± 0.0238 a

rs699*

T/T (3%)

−0.1228 ± 0.0592b

APOA5

0.012

0.0018

A/A (42%)

0a

0.006

−3 A/G

G/A (45%)

0.0678 ± 0.0213b

rs651821

G/G (13%)

0.0474 ± 0.0332ab

APOA5

0.0137

0.0035

T/T (42%)

0a

0.0072

T-1131C

T/C (44%)

0.0669 ± 0.0213b

rs662799

C/C (34%)

0.0427 ± 0.0339ab

HDL-Cholesterol (HDL-C)

APOA5

0.126

0.0002

A/A (42%)

0a

0.0065

−3 A/G

G/A (45%)

−0.0317 ± 0.0100b

rs651821

G/G (13%)

−0.0105 ± 0.0155ab

APOA5

0.01476

0.0002

T/T (42%)

0a

0.0072

T-1131C

T/C (44%)

−0.0314 ± 0.0100b

rs662799

C/C (34%)

−0.0115 ± 0.0159ab

CEPT

0.2302

0.0017

C/C (26%)

0a

0.0271

Ile405Val

C/T (47%)

0.0263 ± 0.0115b

rs5882*

T/T (26%)

0.0017 ± 0.0131a

Triglycerides (TG)

CETP

0.0092

0.3779

C/C (36%)

0ab

0.0300

C-4502T

T/C (49%)

−0.0095 ± 0.0051a

rs183130

T/T (15%)

0.0073 ± 0.0073b

CETP

0.0087

0.399

G/G (28%)

0ab

0.0032

G-971A

A/G (50%)

−0.0106 ± 0.0057a

rs4783961

A/A (22%)

0.0087 ± 0.0068b

Ratio Total Cholesterol/ HDL-Cholesterol

APOC3

0.2263

0.7503

C/C (33%)

0a

0.0137

SstI

C/G (46%)

0.0081 ± 0.0030 b

rs5128*

G/G (21%)

0.0085 ± 0.0039 b

APOA5

0.0016

0.5195

A/A (42%)

0a

<0.0001

−3 A/G

G/A (45%)

0.0128 ± 0.0028 b

rs651821

G/G (13%)

0.0053 ± 0.0044ab

APOA5

0.0018

0.62

T/T (42%)

0a

<0.0001

T-1131C

T/C (44%)

0.0126 ± 0.0028b

rs662799

C/C (14%)

0.0050 ± 0.0045ab

 

CETP

0.188

0.8473

G/G (28%)

0ab

0.0483

G-971A

A/G (50%)

−0.0055 ± 0.0033a

rs4783961

A/A (22%)

0.0022 ± 0.0039b

ApoB100

APOC3

0.0374

0.0399

C/C (33%)

0a

0.0073

SstI

C/G (46%)

0.0179 ± 0.0058 b

rs5128*

G/G (21%)

0.0145 ± 0.0076 ab

APOA4

0.0277

0.0221

A/A (33%)

0a

0.0052

Asn147Ser

A/G (45%)

0.0178 ± 0.0058b

rs5104

G/G (22%)

0.0177 ± 0.0073b

APOA5

0.0006

0.091

A/A (42%)

0a

0.0002

−3 A/G

G/A (45%)

0.0229 ± 0.0055b

rs651821

G/G (13%)

0.0086 ± 0.0086ab

APOA5

0.0009

0.0516

T/T (42%)

0a

0.0002

T-1131C

T/C (44%)

0.0227 ± 0.0055b

rs662799

C/C (34%)

0.0117 ± 0.0088ab

  1. β regression coefficient, P values are calculated with normalized values; β regression coefficient are derived from absolute values, a,b Means with different subscript letters for one SNP are significantly different after adjustment for Tukey test; * Genotype frequency is different between the Inuit and Caucasian populations; The model includes the SNP, n-3 PUFA in RBCs, and the interaction term with adjustment for the effects of age, sex, BMI, and daily energy intake.